The difficulty of identifying susceptibility genes for common diseases has
polarized geneticists' views on what disease models are appropriate and how
best to proceed once high-density genome maps become available. Different
disease models have different implications for using linkage or linkage-dis
equilibrium-based approaches for mapping complex disease genes. We argue th
at the choice of study population is a critical factor when designing a stu
dy, and that genetically simplified isolates are more useful than diverse c
ontinental populations under most assumptions.